You Searched For "gilead remdesivir" and got 20 results
Sort By:
3 mins read
The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients
If the inhaled version of remdesivir works, it "could have significant implications in helping to s…
Andrew Dunn
3 mins read
The US government's supply of remdesivir — the only drug proved to treat the coronavirus — is due to run out at the end of June
The number of US COVID-19 patients requiring remdesivir outnumbers available stocks by two to one, …
Bill Bostock
3 mins read
Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK'd its emergency use
Some hospitals are having a hard time getting remdesivir for their patients. The government is deci…
Lydia Ramsey,Andrew Dunn
3 mins read
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…
Andrew Dunn
6 mins read
Dispensed: A week of drug developments, the plan to restart hospitals, and some non-coronavirus news
Welcome to Dispensed, BI's weekly healthcare newsletter. This week, the TLDR on remdesivir, a promi…
Lydia Ramsey
3 mins read
US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results
FDA is reportedly preparing to allow emergency use of remdesivir as soon as today. The treatment he…
Andrew Dunn
1 min read
Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
One of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID…
Andrew Dunn
1 min read
Study results for a leading potential coronavirus treatment were accidentally released by the WHO and then taken down
About 14% of severe coronavirus patients taking the drug remdesivir died compared to 13% who got a …
Andrew Dunn
2 mins read
Noida-based Jubilant inks packs with Gilead to produce, sell remdesivir
The pact allows Jubilant to register, manufacture and sell remdesivir in 127 countries, includin…
1 min read
COVID-19: Jubilant Life inks licensing agreement with Gilead for remdesivir
The EUA is based on available data from two global clinical trials -- US National Institute for Al…
PTI
1 min read
Dr Reddy's inks pact with Gilead to manufacture COVID-19 drug Remdesivir
The company will receive technology transfer from Gilead for manufacturing of the drug, it added…
PTI
2 mins read
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
1 min read
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
The EUA is based on available data from two global clinical trials – US National Institute for All…
PTI
2 mins read
Gilead slides 4% after COVID-19 drug shows limited benefit in moderately ill patients
Patients who received remdesivir for five days were 65% more likely to show signs of recovery than …
Saloni Sardana
6 mins read
The 'most promising' coronavirus treatment faces its biggest test yet. Clinical data for Gilead's drug remdesivir is coming in a matter of weeks.
In that account, the patient who was the first confirmed case of COVID-19 in the US received remdes…
Andrew Dunn
2 mins read
Gilead surges 17% on report that drug shows effectiveness against COVID-19
In a Chicago hospital, all patients with Covid-19 treated with Gilead's Remdesivir were discharged …
Carmen Reinicke
3 mins read
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
2 mins read
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
5 mins read
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
2 mins read
Sen. Rand Paul may have violated insider trading law by failing to disclose wife's COVID drug stock purchases
A watchdog group is asking the Senate Ethics Committee to investigate Paul after his wife purchased…